Daewoong Pharmaceutical Co., Ltd (KRX:069620)
South Korea · Delayed Price · Currency is KRW
182,000
-3,100 (-1.67%)
Last updated: Feb 26, 2026, 11:12 AM KST
Revenue by Segment
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 |
|---|
Manufacturing and Sales of Pharmaceuticals | 1.46T | 1.41T | 1.32T | 1.18T | 1.08T | | | | | |
Manufacturing and Sales of Pharmaceuticals Growth | 3.45% | 7.06% | 11.17% | 9.68% | -6.50% | | | | | |
| 38.40B | 23.65B | 9.84B | 7.80B | 6.14B | | | | | |
| 62.37% | 140.29% | 26.22% | 26.90% | -24.36% | | | | | |
| 7.19B | 8.26B | 5.23B | 1.47B | 1.54B | | | | | |
| -12.94% | 57.92% | 257.10% | -4.88% | 17.49% | | | | | |
| -81.00B | -66.10B | -51.58B | -40.58B | -32.07B | | | | | |
| 1.42T | 1.38T | 1.28T | 1.15T | 1.06T | | | | | |
| 3.44% | 7.44% | 11.03% | 9.24% | -5.21% | | | | | |
Revenue by Geography
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 |
|---|
| 252.56B | 212.15B | 184.96B | 117.89B | 92.92B | | | | | |
| 19.05% | 14.70% | 56.89% | 26.87% | - | | | | | |
| 1.25T | 1.23T | 1.15T | 1.08T | 994.57B | | | | | |
| 1.78% | 7.20% | 6.61% | 8.15% | - | | | | | |
| -81.00B | -66.10B | -51.58B | -40.58B | -32.07B | | | | | |
| 1.42T | 1.38T | 1.28T | 1.15T | 1.06T | | | | | |
| 3.44% | 7.44% | 11.03% | 9.24% | - | | | | | |
Source: S&P Global Market Intelligence.